ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3016

Measuring the Impact of an Early RA Support and Education Program Using a Program Evaluation with Patient Identified Outcomes

Adena Batterman1, Kathryn Klingenstein1, Roberta Horton1, Linda Leff2, Theodore R. Fields3 and Vivian P. Bykerk4, 1Social Work Programs, Hospital for Special Surgery, New York, NY, 2Nursing, Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 4Rheumatology, Hospital for Special Surgery, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, evaluation and patient outcomes, Support and Education Groups

  • Tweet
  • Email
  • Print
Session Information

Title: Innovations in Rheumatologic Care

Session Type: Abstract Submissions (ARHP)

Background/Purpose

The Early RA Support and Education Program addresses the unique psycho-educational needs of people recently diagnosed (<2yr) with RA.  This free monthly program is co-facilitated by an MSW and RN and was developed based on a needs assessment with patient input; it features an RA- focused lecture followed by a support group, aimed at enhancing emotional coping and disease management. In order to measure program impact on concerns most relevant to new RA patients, we developed an evaluation tool incorporating patient identified outcomes (Hewlett, 2003), on which we previously reported. Since that time, we have piloted the evaluation and now report on the results.

Methods

Through a multi-level collection of data, we identified patient derived program outcomes  and  language most relevant  to participants. This process yielded 3 key domains: Managing RA, Connecting with Others with RA and Coping with the Emotional Impact (Wolrich, 2011).  From this data we created a 20-item evaluation, using a 6 point Likert scale and open-ended questions, which incorporates patient identified outcomes under each of the domains. This new tool was administered to participants after each of 12 monthly sessions.

Results

127 evaluations were completed from 180 participants. Demographics:  Gender:  93%F; Mean age:  49; Ethnicity: White 59%;  African American  19%; Asian American  11%; Latino  11% ;  Education:  College or higher: 92%. Results indicate % of participant agreement (either “completely” or “a great deal”) with the following Likert scale question statements, which represent each of the 3 key domains.  I. MANAGING RA: As a result of this session, I feel… “more prepared to discuss my RA treatment with my doctor” (84%); “I can make informed choices about my RA” (90%).  II.CONNECTING WITH OTHERS: “Speaking with other group members, I feel more hopeful about my RA” (77%).  “Sharing information and feelings in the group helps me cope with RA” (89%). III EMOTIONAL IMPACT: Participating in this program makes me feel…“more confident in managing my RA“(79%); “my RA is less disruptive to my daily life than it was before” (61%).

Responses to open ended questions re learning and impact supported the program’s value within the 3 domains:  Managing ( ”will follow up with MD about what I learned”); Connecting (“I don’t feel so alone”);  Emotional Coping (“learned ways to deal with stress of RA”).

Conclusion

Evaluation results indicate that in domains I and II, and in domain III, “more confident in managing my RA”, the program is making a strong  positive impact . In domain III, “ RA is less disruptive to my daily life,” results reflect positive impact, though not as marked as in other questions. Future work is needed to explore how patients define “disruptive”  and develop targeted content to address this for future groups. Future research might also follow participants longitudinally, to determine how program participation over time, and other variables, impact this outcome. This tool was administered to measure how effectively the program meets patient identified needs. Our process can serve as a model for including the patient perspective in evaluating outcomes in other disease specific support and education programs.


Disclosure:

A. Batterman,
None;

K. Klingenstein,
None;

R. Horton,
None;

L. Leff,
None;

T. R. Fields,

Pfizer Pharmaceuticals,

8;

V. P. Bykerk,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measuring-the-impact-of-an-early-ra-support-and-education-program-using-a-program-evaluation-with-patient-identified-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology